Daniel Arias
Stock Analyst at Stifel Nicolaus
(4.34)
# 1,330
Out of 4,835 analysts
518
Total ratings
49.6%
Success rate
8.7%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Reiterated: Buy | $180 | $146.93 | +22.51% | 28 | Aug 30, 2026 | |
| MXCT MaxCyte | Reiterated: Buy | $4 | $1.16 | +244.83% | 17 | Aug 13, 2026 | |
| MASS 908 Devices | Reiterated: Buy | $10 → $12 | $9.52 | +26.05% | 17 | Aug 12, 2026 | |
| ALMR Alamar Biosciences | Reiterated: Buy | $28 → $32 | $27.66 | +15.69% | 3 | Aug 11, 2026 | |
| MRVI Maravai LifeSciences Holdings | Reiterated: Buy | $6 → $8 | $6.53 | +22.51% | 25 | Aug 11, 2026 | |
| QGEN Qiagen | Reiterated: Hold | $40 | $42.13 | -5.06% | 21 | Aug 11, 2026 | |
| TXG 10x Genomics | Reiterated: Buy | $50 | $68.59 | -27.10% | 26 | Aug 11, 2026 | |
| RPID Rapid Micro Biosystems | Reiterated: Buy | $8 | $1.23 | +553.06% | 7 | Aug 10, 2026 | |
| BLLN BillionToOne | Reiterated: Buy | $145 | $98.77 | +46.81% | 4 | Aug 6, 2026 | |
| BRKR Bruker | Reiterated: Hold | $45 → $50 | $53.43 | -6.42% | 24 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $100 → $110 | $124.31 | -11.51% | 29 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $600 → $650 | $609.82 | +6.59% | 33 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $380 → $420 | $408.34 | +2.86% | 29 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $225 | $206.45 | +8.99% | 49 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 → $180 | $157.38 | +14.37% | 18 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,400 → $1,600 | $1,289.56 | +24.07% | 30 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $60 → $50 | $59.01 | -15.27% | 12 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $8 → $15 | $14.81 | +1.28% | 19 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $207 | $165.18 | +25.32% | 32 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $260 → $220 | $200.15 | +9.92% | 27 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $65 → $50 | $72.12 | -30.67% | 28 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.47 | +241.30% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.21 | n/a | 9 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $4.20 | n/a | 13 | Mar 1, 2024 |
Agilent Technologies
Aug 30, 2026
Reiterated: Buy
Price Target: $180
Current: $146.93
Upside: +22.51%
MaxCyte
Aug 13, 2026
Reiterated: Buy
Price Target: $4
Current: $1.16
Upside: +244.83%
908 Devices
Aug 12, 2026
Reiterated: Buy
Price Target: $10 → $12
Current: $9.52
Upside: +26.05%
Alamar Biosciences
Aug 11, 2026
Reiterated: Buy
Price Target: $28 → $32
Current: $27.66
Upside: +15.69%
Maravai LifeSciences Holdings
Aug 11, 2026
Reiterated: Buy
Price Target: $6 → $8
Current: $6.53
Upside: +22.51%
Qiagen
Aug 11, 2026
Reiterated: Hold
Price Target: $40
Current: $42.13
Upside: -5.06%
10x Genomics
Aug 11, 2026
Reiterated: Buy
Price Target: $50
Current: $68.59
Upside: -27.10%
Rapid Micro Biosystems
Aug 10, 2026
Reiterated: Buy
Price Target: $8
Current: $1.23
Upside: +553.06%
BillionToOne
Aug 6, 2026
Reiterated: Buy
Price Target: $145
Current: $98.77
Upside: +46.81%
Bruker
Aug 5, 2026
Reiterated: Hold
Price Target: $45 → $50
Current: $53.43
Upside: -6.42%
Aug 5, 2026
Rated: Hold
Price Target: $100 → $110
Current: $124.31
Upside: -11.51%
Aug 5, 2026
Rated: Buy
Price Target: $600 → $650
Current: $609.82
Upside: +6.59%
Aug 5, 2026
Rated: Hold
Price Target: $380 → $420
Current: $408.34
Upside: +2.86%
Aug 4, 2026
Reiterated: Buy
Price Target: $225
Current: $206.45
Upside: +8.99%
Aug 3, 2026
Reiterated: Buy
Price Target: $130 → $180
Current: $157.38
Upside: +14.37%
Aug 3, 2026
Reiterated: Buy
Price Target: $1,400 → $1,600
Current: $1,289.56
Upside: +24.07%
Aug 3, 2026
Reiterated: Hold
Price Target: $60 → $50
Current: $59.01
Upside: -15.27%
Jul 30, 2026
Rated: Hold
Price Target: $8 → $15
Current: $14.81
Upside: +1.28%
Jul 29, 2026
Reiterated: Buy
Price Target: $207
Current: $165.18
Upside: +25.32%
Jul 22, 2026
Reiterated: Buy
Price Target: $260 → $220
Current: $200.15
Upside: +9.92%
May 7, 2026
Reiterated: Hold
Price Target: $65 → $50
Current: $72.12
Upside: -30.67%
Nov 10, 2025
Reiterated: Buy
Price Target: $5
Current: $1.47
Upside: +241.30%
Jan 22, 2025
Rated: Hold
Price Target: n/a
Current: $8.21
Upside: n/a
Mar 1, 2024
Reiterated: Buy
Price Target: $5
Current: $4.20
Upside: n/a